The pulmonary-proteoliposome as a new therapeutic approach for Coronaviruses
We are proposing the use of pulmonary-proteoliposome as a new therapeutic approach for Coronaviruses. The designed strategy represents a potential treatment to reduce the overall viral load in the lungs and to help the immune system to successfully stave off the infection.
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2020-10-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/21645515.2020.1758534 |
| _version_ | 1797677298851250176 |
|---|---|
| author | Isidoro Feliciello Alfredo Procino |
| author_facet | Isidoro Feliciello Alfredo Procino |
| author_sort | Isidoro Feliciello |
| collection | DOAJ |
| description | We are proposing the use of pulmonary-proteoliposome as a new therapeutic approach for Coronaviruses. The designed strategy represents a potential treatment to reduce the overall viral load in the lungs and to help the immune system to successfully stave off the infection. |
| first_indexed | 2024-03-11T22:43:11Z |
| format | Article |
| id | doaj.art-b7612838ca2d41169fccfd68060dd88b |
| institution | Directory Open Access Journal |
| issn | 2164-5515 2164-554X |
| language | English |
| last_indexed | 2024-03-11T22:43:11Z |
| publishDate | 2020-10-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Human Vaccines & Immunotherapeutics |
| spelling | doaj.art-b7612838ca2d41169fccfd68060dd88b2023-09-22T08:51:48ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2020-10-0116102373237310.1080/21645515.2020.17585341758534The pulmonary-proteoliposome as a new therapeutic approach for CoronavirusesIsidoro Feliciello0Alfredo Procino1University of Naples Federico IIUniversity of Naples Federico IIWe are proposing the use of pulmonary-proteoliposome as a new therapeutic approach for Coronaviruses. The designed strategy represents a potential treatment to reduce the overall viral load in the lungs and to help the immune system to successfully stave off the infection.http://dx.doi.org/10.1080/21645515.2020.1758534coronavirusliposomesars-cov-2 |
| spellingShingle | Isidoro Feliciello Alfredo Procino The pulmonary-proteoliposome as a new therapeutic approach for Coronaviruses Human Vaccines & Immunotherapeutics coronavirus liposome sars-cov-2 |
| title | The pulmonary-proteoliposome as a new therapeutic approach for Coronaviruses |
| title_full | The pulmonary-proteoliposome as a new therapeutic approach for Coronaviruses |
| title_fullStr | The pulmonary-proteoliposome as a new therapeutic approach for Coronaviruses |
| title_full_unstemmed | The pulmonary-proteoliposome as a new therapeutic approach for Coronaviruses |
| title_short | The pulmonary-proteoliposome as a new therapeutic approach for Coronaviruses |
| title_sort | pulmonary proteoliposome as a new therapeutic approach for coronaviruses |
| topic | coronavirus liposome sars-cov-2 |
| url | http://dx.doi.org/10.1080/21645515.2020.1758534 |
| work_keys_str_mv | AT isidorofeliciello thepulmonaryproteoliposomeasanewtherapeuticapproachforcoronaviruses AT alfredoprocino thepulmonaryproteoliposomeasanewtherapeuticapproachforcoronaviruses AT isidorofeliciello pulmonaryproteoliposomeasanewtherapeuticapproachforcoronaviruses AT alfredoprocino pulmonaryproteoliposomeasanewtherapeuticapproachforcoronaviruses |